On consolidated basis
Quarter ended December 2024 compared with Quarter ended December 2023.
Net sales (including other operating income) of Zydus Wellness has increased 14.56% to Rs 461.9 crore. Operating profit margin has jumped from 3.15% to 3.20%, leading to 16.54% rise in operating profit to Rs 14.80 crore. Raw material cost as a % of total sales (net of stock adjustments) increased from 53.14% to 55.06%. Purchase of finished goods cost fell from 2.56% to 1.42%. Employee cost decreased from 10.09% to 10.06%. Other expenses fell from 31.31% to 30.62%. Selling and administration expenses fell from 11.28% to 11.27%. Loss on forex transaction rose from 0.05% to 0.06%. Other income rose 11.76% to Rs 3.8 crore. PBIDT rose 15.53% to Rs 18.6 crore. Provision for interest fell 47.62% to Rs 3.3 crore. PBDT rose 56.12% to Rs 15.3 crore. Provision for depreciation fell 14.75% to Rs 5.2 crore. Profit before tax grew 172.97% to Rs 10.10 crore. Share of profit/loss were nil in both the periods. Provision for tax was expense of Rs 3.7 crore, compared to Rs 3.4 crore. Effective tax rate was 36.63% compared to 91.89%. Minority interest was nil in both the periods. Net profit attributable to owners of the company increased 2,033.33% to Rs 6.40 crore. Promoters’ stake was 69.62% as of 31 December 2024 ,compared to 69.15% as of 31 December 2023 .
For year-to-date (YTD) results analysis.
Net sales (including other operating income) of Zydus Wellness has increased 16.22% to Rs 1795.8 crore. Operating profit margin has jumped from 9.45% to 10.56%, leading to 29.93% rise in operating profit to Rs 189.70 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 45.42% to 42.76%. Purchase of finished goods cost rose from 4.03% to 4.30%. Employee cost increased from 9.28% to 9.34%. Other expenses rose from 31.59% to 32.80%. Selling and administration expenses rose from 13.57% to 14.03%. Other income rose 29.29% to Rs 12.8 crore. PBIDT rose 29.89% to Rs 202.5 crore. Provision for interest fell 56.42% to Rs 7.8 crore. PBDT rose 41.09% to Rs 194.7 crore. Provision for depreciation fell 16.02% to Rs 15.2 crore. Profit before tax grew 49.71% to Rs 179.50 crore. Share of profit/loss were nil in both the periods. Provision for tax was debit of Rs 10.4 crore, compared to credit of Rs 10.9 crore. Effective tax rate was 5.61% compared to negative 10.31%.Minority interest was nil in both the periods. Net profit attributable to owners of the company increased 50.09% to Rs 175.00 crore. Promoters’ stake was 69.62% as of 31 December 2024 ,compared to 69.15% as of 31 December 2023 .
Full year results analysis.
Net sales (including other operating income) of Zydus Wellness has increased 3.24% to Rs 2327.8 crore. Operating profit margin has declined from 14.95% to 13.24%, leading to 8.60% decline in operating profit to Rs 308.20 crore. Raw material cost as a % of total sales (net of stock adjustments) decreased from 47.36% to 44.30%. Purchase of finished goods cost fell from 4.92% to 4.81%. Employee cost increased from 7.20% to 8.27%. Other expenses rose from 26.01% to 29.43%. Selling and administration expenses rose from 11.14% to 12.78%. Other income rose 183.67% to Rs 13.9 crore. PBIDT fell 5.85% to Rs 322.1 crore. Provision for interest rose 49.07% to Rs 24 crore. Loan funds rose to Rs 328.70 crore as of 31 March 2024 from Rs 297.30 crore as of 31 March 2023. Inventories rose to Rs 467.60 crore as of 31 March 2024 from Rs 457.50 crore as of 31 March 2023. Sundry debtors were higher at Rs 283.30 crore as of 31 March 2024 compared to Rs 207.80 crore as of 31 March 2023. Cash and bank balance rose to Rs 239.50 crore as of 31 March 2024 from Rs 38.10 crore as of 31 March 2023. Investments rose to Rs 77.60 crore as of 31 March 2024 from Rs 70.00 crore as of 31 March 2023 . PBDT fell 8.56% to Rs 298.1 crore. Provision for depreciation fell 4.80% to Rs 23.8 crore. Fixed assets declined from Rs 825.40 crore as of 31 March 2023 to Rs 797.20 crore as of 31 March 2024. Intangible assets stood at Rs 3,920.00 crore. Profit before tax down 8.87% to Rs 274.30 crore. Share of profit/loss were nil in both the periods. Extraordinary items were decreased to Rs -14.20 crore. Provision for tax was credit of Rs 6.8 crore, compared to credit of Rs 19.5 crore. Effective tax rate was negative 2.61% compared to negative 6.70%. Minority interest was nil in both the periods. Net profit attributable to owners of the company decreased 14.01% to Rs 266.90 crore. Equity capital stood at Rs 63.60 crore as of 31 March 2024 to Rs 63.60 crore as of 31 March 2023. Per share face Value remained same at Rs 10.00. Promoters’ stake was 69.62% as of 31 March 2024 ,compared to 66.45% as of 31 March 2023 . Cash flow from operating activities increased to Rs 246.40 crore for year ended March 2024 from Rs 91.70 crore for year ended March 2023. Cash flow used in acquiring fixed assets during the year ended March 2024 stood at Rs 28.50 crore, compared to Rs 45.00 crore during the year ended March 2023. Other Highlights
Growth
in Q3 FY25 was driven by robust consumer demand in the personal care segment,
which posted double-digit growth of 50.3% YoY, while food and nutrition segment
recorded a growth of 8.8% YoY.
During 9M FY25, personal care segment grew 39.2% YoY and food
and nutrition segment grew 11.8% YoY.
During the quarter, the company completed acquisition of
100% equity share capital of Naturell (India). Naturell (India) specializes in
manufacturing, research and development, marketing of nutrition bars, protein
cookies, protein chips, and health food products under the Ritebite Max Protein
(Protein fuelled healthy snacks) and Ritebite (fibre-enriched snacks).
The company is targeting 8-10% of its total revenue from
international business in next 4-5 years.
| Zydus Wellness : Consolidated Results | | | Quarter ended | Year to Date | Year ended |
|---|
| Particulars | 202412 | 202312 | Var.(%) | 202412 | 202312 | Var.(%) | 202403 | 202303 | Var.(%) |
|---|
| Net Sales (including other operating income) | 461.90 | 403.20 | 14.56 | 1,795.80 | 1,545.20 | 16.22 | 2,327.80 | 2,254.80 | 3.24 | | OPM (%) | 3.20 | 3.15 | 5 bps | 10.56 | 9.45 | 111 bps | 13.24 | 14.95 | -171 bps | | OP | 14.80 | 12.70 | 16.54 | 189.70 | 146.00 | 29.93 | 308.20 | 337.20 | -8.60 | | Other Inc. | 3.80 | 3.40 | 11.76 | 12.80 | 9.90 | 29.29 | 13.90 | 4.90 | 183.67 | | PBIDT | 18.60 | 16.10 | 15.53 | 202.50 | 155.90 | 29.89 | 322.10 | 342.10 | -5.85 | | Interest | 3.30 | 6.30 | -47.62 | 7.80 | 17.90 | -56.42 | 24.00 | 16.10 | 49.07 | | PBDT | 15.30 | 9.80 | 56.12 | 194.70 | 138.00 | 41.09 | 298.10 | 326.00 | -8.56 | | Depreciation | 5.2 | 6.1 | -14.75 | 15.2 | 18.1 | -16.02 | 23.8 | 25 | -4.80 | | PBT | 10.10 | 3.70 | 172.97 | 179.5 | 119.9 | 49.71 | 274.3 | 301 | -8.87 | | Share of Profit/(Loss) from Associates | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | PBT before EO | 10.1 | 3.7 | 172.97 | 179.5 | 119.9 | 49.71 | 274.3 | 301 | -8.87 | | EO Income | 0 | 0 | - | 5.9 | -14.2 | LP | -14.2 | -10.1 | -40.59 | | PBT after EO | 10.1 | 3.7 | 172.97 | 185.4 | 105.7 | 75.40 | 260.1 | 290.9 | -10.59 | | Taxation | 3.7 | 3.4 | 8.82 | 10.4 | -10.9 | PL | -6.8 | -19.5 | 65.13 | | PAT | 6.4 | 0.3 | 2,033.33 | 175 | 116.6 | 50.09 | 266.9 | 310.4 | -14.01 | | Minority Interest (MI) | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit | 6.4 | 0.3 | 2,033.33 | 175 | 116.6 | 50.09 | 266.9 | 310.4 | -14.01 | | P/(L) from discontinued operations net of tax | 0 | 0 | - | 0 | 0 | - | 0 | 0 | - | | Net profit after discontinued operations | 6.4 | 0.3 | 2,033.33 | 175 | 116.6 | 50.09 | 266.9 | 310.4 | -14.01 | | EPS (Rs)* | 1.01 | 0.05 | 2,033.33 | 26.63 | 18.84 | 41.31 | 43.11 | 47.30 | -8.87 | | | * EPS is on current equity of Rs 63.63 crore, Face value of Rs 10, Excluding extraordinary items. | | # EPS is not annualised | | bps : Basis points | | EO : Extraordinary items | | Figures in Rs crore | | Source: Capitaline Corporate Database |
|
|